ESR1 and breast cancer: We found that between 6 and 24 hours after estrogen/β-estradiol (E2) treatment (30 nM) of the ER+ BC cells that were cultured in E2-deprived condition (see Methods), the expression of GT3-INCP showed an increase at both the RNA and protein level (Figure 9, A and B).